Besides enabling the identification and selection of the most suitable anti-cancer drugs to treat a tumour with different ELF4 expression signatures, a multiscale understanding of ELF4 across different cancer types will likely yield better prediction of disease outcome. Here, ELF4 is linked to cancer.